Press release - 24/09/2025 No GPS in the head: How the brain flexibly switches between internal maps Since their discovery in 2004, the grid cells in the brain, which are important for our orientation, have been regarded as a kind of “GPS in the head.” However, scientists at the DKFZ and Heidelberg University Hospital have now shown that grid cells work much more flexibly than previously assumed. In experiments with mice, the researchers found that the cells adapt their activity to different reference points depending on the situation.
Press release - 23/09/2025 Mutation in non-coding DNA worsens leukaemia prognosis Ulm study uncovers previously unknown disease-promoting mechanism Why is blood cancer particularly aggressive in some patients? Researchers at Ulm University Hospital have characterised a mutation in the so-called NOTCH1 gene that significantly influences the prognosis of chronic lymphocytic leukaemia (CLL). Remarkably, this mutation is located in the non-coding region of the gene – an area of DNA long considered less relevant for disease mechanisms.
Press release - 23/09/2025 Institutional Partnership: Heidelberg and Harvard Sign Memorandum of Understanding On the basis of the cooperative relations that have developed over time, Heidelberg University and Harvard University are going to deepen and expand their cooperation. They have signed a Memorandum of Understanding to that effect. As an institutional internationalization project, the state of Baden-Württemberg is providing ten million euros to support this initiative, which is part of the state’s “Global Partnership in Science” activities.
Press release - 23/09/2025 Not all ALK fusions act the same: Variants influence treatment success in lung cancer About five percent of lung adenocarcinomas, one of the most common forms of lung cancer, are driven by a faulty fusion of two genes, EML4 and ALK. This fusion results in different variants, and until now, clinicians have treated all patients with these fusions the same way. However, new research led by scientists from the German Cancer Research Center (DKFZ) and Stanford University shows that not all fusion variants behave alike.
Press release - 22/09/2025 Research into novel microelectrodes: Dr. Maximilian Becker receives NanoMatFutur funding With the FeMEA project – Ferroelectric Microelectrodes for Biomedical Applications – Hahn-Schickard is setting a pioneering course in bioelectronics research. The aim of the project is to develop novel microelectrode arrays in which ferroelectric materials are used as functional interfaces in CMOS chips for the first time.
Press release - 17/09/2025 Fat cells are the guardians of our health Researchers have discovered part of the answer to why some people with obesity or diabetes develop fatty liver disease while others remain healthier. They showed that fat cells have their own protective mechanism that prevents them from dying prematurely under stress. If this mechanism fails, the fat cells disintegrate. This can lead to tissue damage, inflammation and serious metabolic disorders.
Press release - 17/09/2025 AI model predicts disease risks decades in advance Scientists from the European Molecular Biology Laboratory (EMBL) and the German Cancer Research Center (DKFZ) have developed an AI model that assesses the long-term individual risk for more than 1,000 diseases. The model, which was trained and tested using anonymized medical data from the UK and Denmark, can predict health events over a period of more than a decade.
Press release - 16/09/2025 New CRISPR method leads to a better understanding of cell functions The 2020 Nobel Prize in Chemistry was awarded for the development of CRISPR/Cas9, a method also known as “gene scissors”, which enables researchers to better understand how human cells function and stay healthy. Researchers at the University of Stuttgart have further developed CRISPR for this purpose. They present their CRISPRgenee method in Cell Reports Methods.
Press release - 15/09/2025 How HIV enters the genome – Researchers identify previously unknown mechanism Researchers at Heidelberg Uni Hospital have decoded a previously unknown mechanism by which HIV-1 selects its integration targets in the human genome. A research team identified RNA:DNA hybrids as molecular signposts for the virus. These findings reveal a vulnerability in the life cycle of HIV and provide therapeutic approaches for specifically controlling HIV reservoirs in the body. This has been one of the obstacles to curative HIV therapies.
Press release - 12/09/2025 In bad company: Immune cells in the tumor environment determine the success of therapy for childhood brain tumors The cellular environment of a tumor can either support or sabotage recovery. The most comprehensive study to date on the tumor microenvironment in low-grade gliomas, conducted by KiTZ, Jena University Hospital, the DKFZ, and Heidelberg University Hospital, shows what a supportive or obstructive “neighborhood” looks like in childhood brain tumors. The study also provides clues as to how tumor communication might be blocked.
Press release - 09/09/2025 Soft materials for smarter robots Soft robots, robot systems made of soft materials, open up new perspectives for medical technology and industry. Jun.-Prof. Dr. Aniket Pal from the University of Stuttgart is conducting research into viscoelastic materials that have the potential to embed intelligent functions in soft robots. He is receiving 1.5 million euros in funding for this research as part of the Emmy Noether Program. The funding period began on September 1, 2025.
Press release - 09/09/2025 Signals from the brain reveal what color a person is seeing Visual areas of the brain can reveal the colors a person is seeing while watching moving color rings. This was the result of a study by the University of Tübingen. Using MRI scanning they recorded images from the brains of subjects who were observing visual stimuli, and identified signals for red, green and yellow. The pattern of brain activity appeared similar in subjects, meaning that the color they saw could be predicted simply by comparison…